Drug monitoring, in the context of healthcare and pharmacology, refers to the process of tracking and evaluating the use, safety, efficacy, and overall impact of medications in clinical practice.

Biond Biologics reveals at the 2024 AACR Annual Meeting, the introduction of their pioneering anti-ILT3 antibody, BND-35, designed to transform the tumor microenvironment.

Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung condition causing scarring and stiffness, which makes breathing harder over time.

REGENXBIO Reveals Study in The Lancet on Initial Trial for Single-Dose Gene Therapy ABBV-RGX-314 Targeting Wet Age-Related Macular Degeneration.

Targeted therapy is a type of cancer treatment that uses drugs or other substances to specifically attack cancer cells without harming normal cells as much as possible.

Neurocrine Biosciences Launches Early-Stage Trial for New VMAT2 Blocker, NBI-1065890, in Adult Participants.

Advancing GPCR-Targeted Therapy: Tectonic Therapeutics' GEODe Platform Overcomes Discovery Challenges.

Gilead and Xilio have entered into a unique licensing deal dedicated to the development of an oncology-targeted IL-12 initiative.

A drug delivery system is a method or technology used to transport a pharmaceutical compound into the body to achieve a therapeutic effect.

Ironwood Pharma Reveals Encouraging Outcomes in Phase 2 STARGAZE Study for Apraglutide Treating GI aGVHD Unresponsive to Steroids.

Drug safety evaluation is the process of assessing the safety profile of a pharmaceutical compound throughout its development, from preclinical stages to post-marketing surveillance.

Avalo secures IL-1β monoclonal antibody and reveals plans for a private investment round potentially reaching $185M.